Sign In
Buy SYK
$337.03
+1.07 (+0.318%)
At Close: Aug 05, 2026
Is This MedTech Giant a Buy for Dividend Investors?
05:30am, Wednesday, 09'th Aug 2023
Stryker's net sales and earnings climbed in the second quarter. The company's seemingly modest payout could have many more years of growth ahead.
Stryker (SYK) Reports Q2 Earnings: What Key Metrics Have to Say
05:18pm, Friday, 04'th Aug 2023
Although the revenue and EPS for Stryker (SYK) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street es
Is Stryker Corp (SYK) Fairly Valued? An In-depth Analysis
02:33pm, Friday, 04'th Aug 2023
Today, Stryker Corp ( SYK , Financial) experienced a daily change of 3.27%, with an Earnings Per Share (EPS) of 6.87. The question on the minds of many investors is whether the stock is fairly valued.
Final Trades: Boeing, Stryker & Wynn
01:43pm, Friday, 04'th Aug 2023
The "Halftime Report" traders give their top picks to watch for the second half.
Stryker CEO: We're in the midst of 'supercycle of innovation' across our capital equipment business
12:13pm, Friday, 04'th Aug 2023
Kevin Lobo, Stryker CEO, joins 'Squawk on the Street' to discuss the key factors for Stryker's growth, how long the backlog of procedures will last for the company, and Stryker's next catalyst for gro
Stryker (SYK) Q2 Earnings Beat Estimates, Volume Improves
10:32am, Friday, 04'th Aug 2023
Stryker's (SYK) second-quarter earnings reflect strong performance across its segments. However, unfavorable currency movement hurts sales growth and rising costs affect margins.
Stryker (SYK) Q2 Earnings and Revenues Beat Estimates
06:46pm, Thursday, 03'rd Aug 2023
Stryker (SYK) came out with quarterly earnings of $2.54 per share, beating the Zacks Consensus Estimate of $2.38 per share. This compares to earnings of $2.25 per share a year ago.
Stryker lifts annual profit forecast as demand for its devices picks up
05:05pm, Thursday, 03'rd Aug 2023
Stryker raised its annual profit forecast on Thursday as the medtech company sees strong demand for its medical and surgical devices, aided by a post-pandemic pickup in surgical procedure volumes at h
4 Medical Product Stocks to Buy Amid Recovering Prospects
10:23am, Monday, 31'st Jul 2023
Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should lend support to the Zacks Medical-Products industry. ABT, SYK, ZBH and HAE are well po
HAE or SYK: Which Is the Better Value Stock Right Now?
12:52pm, Wednesday, 19'th Jul 2023
Investors interested in stocks from the Medical - Products sector have probably already heard of Haemonetics (HAE) and Stryker (SYK). But which of these two stocks presents investors with the better v
Here's Why You Should Add Stryker (SYK) Stock to Your Portfolio
10:06am, Thursday, 06'th Jul 2023
Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on the stock.
Bullish Action: Chipotle, Visa, Stryker Break Through Resistance
06:46am, Thursday, 06'th Jul 2023
Chipotle Mexican Grill Inc. NYSE: CMG, Visa Inc. NYSE: V and Stryker Corp. NYSE: SYK may not, at first glance, seem like they have much in common. However, they're part of an elite group: All are S&P
Stryker (SYK) Stock Hits 52-Week High: More Room to Grow?
10:42am, Monday, 03'rd Jul 2023
Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on the stock.
Stryker to announce financial results for its second quarter of fiscal year 2023
04:05pm, Friday, 30'th Jun 2023
Kalamazoo, Michigan, June 30, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for second quarter of fiscal year 2023 on Thursday, August 3, 2023. A press
Elective Surgeries Are On the Rise: 3 Stocks That Can Benefit From This Trend
10:07am, Thursday, 22'nd Jun 2023
The healthcare industry is facing pent-up demand for surgeries. Health insurers may struggle with some additional costs as a result.
